Sacrococcygeal teratoma with preterm delivery: a case report.

Background: Sacrococcygeal teratoma is one of the most frequently prenatally diagnosed neoplasias. Obstetric ultrasound has a role in the diagnosis and management of these tumors during pregnancy. In this report, we describe a multidisciplinary approach in a case of a patient with sacrococcygeal teratomas and preterm delivery, as well as postnatal outcomes.

Prenatal diagnosis of Binder's syndrome: report of two cases.

Objective: Binder syndrome is a rare congenital malformation presenting an abnormal maxilla's development associated to other characteristical facial features, like absence or decreased nasal bridge, short nasal columella, convex upper lip with associated dental Angle Class III malocclusion, atrophy of the nasal mucosa, and absence of the frontal sinus. Mental retardation and other clinical signs may also be present. Two cases of Binder syndrome were diagnosed at 22 weeks of gestation during the second trimester ultrasound (2D).

Analysis of the DNA interaction of copper compounds belonging to the Casiopeínas® antitumoral series.

Casiopeínas® are mixed-chelate copper complexes with antitumor tested potential. Their activity, both in vitro and in vivo, as antiproliferative, cytotoxic, and genotoxic drugs has been assessed. Biological results of these copper compounds have deserved some of them entering clinical trials.

Detection by Urinary GAG Testing of Mucopolysaccharidosis Type II in an At-Risk Spanish Population.

Hunter syndrome (Mucopolysaccharidosis type II) is an inherited lysosomal storage disorder with potentially severe degenerative consequences. Clinical diagnosis is not easy, although biochemical confirmation is straightforward, and sometimes patients are diagnosed at a late age. It is widely believed, for inborn errors of metabolism in general, that early diagnosis and management is of paramount importance for improving the prognosis of the disease.

Compatibility and stability of ternary admixtures of tramadol, haloperidol, and hyoscine N-butyl bromide: retrospective clinical evaluation.

Background: Combination of drugs for subcutaneous infusion is common practice in palliative medicine, however, there is no information pertaining to the compatibility and stability of tramadol combined in ternary admixtures and no information exists regarding its clinical performance.

Methods: Tramadol hydrochloride, haloperidol lactate, and hyoscine N-butyl bromide have been examined for compatibility and stability when combined in solution under conditions mimicking their potential use via subcutaneous infusion in terminal oncology patients. Concentration ranges were 8.